Optimizing a Mobile Health Platform for Sleep Promotion and Obesity Prevention in Children
Children's Hospital of Philadelphia · with Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University of Pennsylvania · NCT05703347
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 8–12 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 5000
- US sites recruiting
- 1
- Study start
- September 21, 2023
- Record last updated
- May 27, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The overall objective of this application is to develop a mobile health platform for the pediatric care setting to promote longer sleep duration for childhood obesity prevention.
Being studied: Fixed sleep goal; Personalized sleep goal; Digital sleep health messaging without virtual study visit; Digital sleep health messaging with virtual study visit; Inactive Parent-Directed Loss-Framed Incentive; Active Parent-Directed Loss-Framed Incentive; Inactive Supportive Feedback; Active Supportive Feedback
Conditions: Insufficient Sleep; Obesity
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Aged 8-12 years olds.
- Insufficient sleep duration (\<8.5 hours per night).
- Body mass index (BMI) between the 50th and 95th percentile for age and sex.
- One child per family.
Exclusion Criteria
- Diagnosed with a chronic disease.
- Diagnosed with a behavioral health problem.
- Diagnosed with a condition that can impact sleep or growth.
- Diagnosed with a condition affecting physical growth and maturation or dietary intake.
- Children with a history of cancer, kidney, GI, musculoskeletal, or sleep disorders.
- Children who will transition to high-school during the study.
- Children using steroids/hormones.
- Children regularly taking medications related to exclusionary medical conditions or that impact sleep.
- Children with a history of significant behavioral health concerns.
- Parent reported PROMIS Parent Proxy Sleep Disturbance - Short Form 8a raw score of ≥28.
Recruiting US locations
Children's Hospital of Philadelphia
Philadelphia, PA 19104
Site contact: Jonathan Mitchell, PhD · mitchellj2@chop.edu
Study contacts (from the official record)
- Jonathan Mitchell, PhD · 2674261473 · mitchellj2@chop.edu
- Abby Salem · 2155902386 · salema1@chop.edu
Similar studies in Pennsylvania
All weight loss studies in Pennsylvania →- RecruitingHealthy volunteersPhase 1
Pharmacogenetics of Response to GLP1R Agonists
University of Maryland, Baltimore
- Location
- Lancaster, PA
- Eligibility basics
- Ages 18–89
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Philadelphia, PA + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingPhase 3
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Amgen
- Location
- Beaver, PA + 51 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 3
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Hoffmann-La Roche
- Location
- West Chester, PA + 43 other US sites
- Eligibility basics
- Ages 18+